Delivery Order SPE2DB24D2109-SPE2DB25FHXHM
- Not listed
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the medication Gilenya 0.5 mg capsule 30s, with a ceiling value of $48,930.98 and a completion date of June 9, 2025. The contract is a firm fixed-price type with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $45,054.04, is for the supply of Gilenya 0.5 mg capsules, a medication used to treat multiple sclerosis. The contract has a firm fixed price and is set to expire on May 14, 2024. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Gilenya 0.5 mg capsules, a specialty medication used to treat multiple sclerosis. The delivery order has a ceiling value of $7,011.41 and a completion date of August 31, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant Indefinite...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $26,448.92 contract is for the supply of Gilenya 0.5 mg capsules, a specialty pharmaceutical product. The delivery order was issued under an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that serves as the primary vehicle for Amerisourcebergen to...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,019.86, is for the delivery of Gilenya 0.5 mg capsules with an ultimate completion date of April 29, 2025. The contract is a firm fixed-price delivery order and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of 30-count capsules of the drug Gilenya 0.5 mg. The contract has a firm fixed price of $9,019.86 and a period of performance through July 10, 2025. The contract is not designated as a set-aside and was awarded on July 9, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Gilenya 0.5 mg capsules. The fixed-price contract has a ceiling value of $16,277.28 and a period of performance through May 12, 2023. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of...
- This is a delivery order award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $18,285.62 firm fixed-price contract is for the supply of Gilenya 0.5 mg capsules. This order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The delivery order, valued at $69,163.45, is for the supply of the prescription medication Gilenya 0.5 mg capsules. The contract is a firm fixed-price delivery order under Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was made by the Defense Logistics Agency (DLA) on May 7, 2025. The $43,935.58 firm fixed-price delivery order is for the provision of the medication Gilenya 0.5 mg capsules, with a performance period extending to May 8, 2025. This order is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which allows the company...
- SPE2DB24D2109Indefinite Delivery Contract
- SPE2DB24D2109-SPE2DB25FHXHMDelivery Order
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Gilenya 0.5 mg capsules, a medication used to treat multiple sclerosis. The contract has a ceiling value of $42,554.38 and a period of performance through June 30, 2025. The contract is a firm fixed-price delivery order, without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This larger IDC enables Amerisourcebergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $42.6k | 6/27/25 |